(NTRS) Northern Trust - Overview
Stock: Wealth Management, Asset Servicing, Asset Management, Banking Services, Custody
| Risk 5d forecast | |
|---|---|
| Volatility | 30.8% |
| Relative Tail Risk | -9.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 17.07 |
| Character TTM | |
|---|---|
| Beta | 1.067 |
| Beta Downside | 1.481 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.96% |
| CAGR/Max DD | 0.60 |
EPS (Earnings per Share)
Revenue
Description: NTRS Northern Trust March 03, 2026
Northern Trust Corporation (NASDAQ: NTRS) is a diversified financial holding company that delivers wealth management, asset servicing, asset management, and banking solutions to corporations, institutions, families, and individuals worldwide. Its operations are split between two primary segments: Asset Servicing, which provides custody, fund administration, securities lending, treasury and cash management, and related services to institutional clients; and Wealth Management, which offers trust, investment, brokerage, and private banking services to high-net-worth individuals and privately-held businesses.
In its most recent quarter (Q4 2025), Northern Trust reported record asset-under-management (AUM) of approximately $1.4 trillion, revenue of $7.2 billion and net income of $12.3 billion, translating to a return on equity (ROE) of 12.5%-the highest in its five-year history.
Key drivers for the firm include the continued growth of the global wealth-management market, which is projected to expand at a 6% CAGR through 2028, and heightened demand for sophisticated asset-servicing solutions as regulatory complexity rises for institutional investors. Additionally, low-interest-rate environments have boosted demand for fee-based advisory and custody services.
For a deeper dive into Northern Trust’s valuation and outlook, you might want to explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 3.46 > 1.0 |
| NWC/Revenue: -643.1% < 20% (prev -431.6%; Δ -211.5% < -1%) |
| CFO/TA 0.03 > 3% & CFO 5.53b > Net Income 1.74b |
| Net Debt (-44.70b) to EBITDA (3.21b): -13.90 < 3 |
| Current Ratio: 0.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (188.6m) vs 12m ago -4.81% < -2% |
| Gross Margin: 56.54% > 18% (prev 0.52%; Δ 5602 % > 0.5%) |
| Asset Turnover: 8.60% > 50% (prev 10.21%; Δ -1.61% > 0%) |
| Interest Coverage Ratio: 0.38 > 6 (EBITDA TTM 3.21b / Interest Expense TTM 6.21b) |
Altman Z'' -2.92
| A: -0.52 (Total Current Assets 63.78b - Total Current Liabilities 155.74b) / Total Assets 177.13b |
| B: 0.07 (Retained Earnings 12.66b / Total Assets 177.13b) |
| C: 0.01 (EBIT TTM 2.33b / Avg Total Assets 166.32b) |
| D: 0.15 (Book Value of Equity 24.15b / Total Liabilities 164.17b) |
| Altman-Z'' Score: -2.92 = D |
Beneish M
| DSRI: none (Receivables none/41.1m, Revenue 14.30b/15.88b) |
| GMI: 0.92 (GM 56.54% / 52.24%) |
| AQI: 1.01 (AQ_t 0.64 / AQ_t-1 0.63) |
| SGI: 0.90 (Revenue 14.30b / 15.88b) |
| TATA: -0.02 (NI 1.74b - CFO 5.53b) / TA 177.13b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of NTRS shares?
Over the past week, the price has changed by +3.45%, over one month by -4.21%, over three months by +12.02% and over the past year by +36.40%.
Is NTRS a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 10
- Sell: 1
- StrongSell: 2
What are the forecasts/targets for the NTRS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 157.1 | 8.2% |
| Analysts Target Price | 157.1 | 8.2% |
NTRS Fundamental Data Overview February 27, 2026
P/E Forward = 14.2653
P/S = 3.4053
P/B = 2.1202
P/EG = 6.7967
Revenue TTM = 14.30b USD
EBIT TTM = 2.33b USD
EBITDA TTM = 3.21b USD
Long Term Debt = 13.52b USD (from longTermDebt, two quarters ago)
Short Term Debt = 12.94b USD (from shortTermDebt, last quarter)
Debt = 16.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -44.70b USD (from netDebt column, last quarter)
Enterprise Value = -19.79b USD (27.56b + Debt 16.43b - CCE 63.78b)
Interest Coverage Ratio = 0.38 (Ebit TTM 2.33b / Interest Expense TTM 6.21b)
EV/FCF = -4.18x (Enterprise Value -19.79b / FCF TTM 4.73b)
FCF Yield = -23.92% (FCF TTM 4.73b / Enterprise Value -19.79b)
FCF Margin = 33.11% (FCF TTM 4.73b / Revenue TTM 14.30b)
Net Margin = 12.15% (Net Income TTM 1.74b / Revenue TTM 14.30b)
Gross Margin = 56.54% ((Revenue TTM 14.30b - Cost of Revenue TTM 6.21b) / Revenue TTM)
Gross Margin QoQ = 58.84% (prev 57.07%)
Tobins Q-Ratio = -0.11 (set to none) (Enterprise Value -19.79b / Total Assets 177.13b)
Interest Expense / Debt = 9.04% (Interest Expense 1.49b / Debt 16.43b)
Taxrate = 26.48% (167.8m / 633.8m)
NOPAT = 1.71b (EBIT 2.33b * (1 - 26.48%))
Current Ratio = 0.41 (Total Current Assets 63.78b / Total Current Liabilities 155.74b)
Debt / Equity = 1.27 (Debt 16.43b / totalStockholderEquity, last quarter 12.96b)
Debt / EBITDA = -13.90 (Net Debt -44.70b / EBITDA 3.21b)
Debt / FCF = -9.44 (Net Debt -44.70b / FCF TTM 4.73b)
Total Stockholder Equity = 12.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.04% (Net Income 1.74b / Total Assets 177.13b)
RoE = 13.45% (Net Income TTM 1.74b / Total Stockholder Equity 12.91b)
RoCE = 8.82% (EBIT 2.33b / Capital Employed (Equity 12.91b + L.T.Debt 13.52b))
RoIC = 6.73% (NOPAT 1.71b / Invested Capital 25.49b)
WACC = 8.65% (E(27.56b)/V(43.99b) * Re(9.85%) + D(16.43b)/V(43.99b) * Rd(9.04%) * (1-Tc(0.26)))
Discount Rate = 9.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.43%
[DCF] Terminal Value 72.75% ; FCFF base≈4.73b ; Y1≈3.99b ; Y5≈3.01b
[DCF] Fair Price = 502.2 (EV 48.87b - Net Debt -44.70b = Equity 93.57b / Shares 186.3m; r=8.65% [WACC]; 5y FCF grow -18.91% → 2.90% )
EPS Correlation: 38.81 | EPS CAGR: 8.70% | SUE: 0.05 | # QB: 0
Revenue Correlation: 84.00 | Revenue CAGR: 21.82% | SUE: 2.85 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.52 | Chg7d=+0.000 | Chg30d=+0.031 | Revisions Net=+8 | Analysts=12
EPS current Year (2026-12-31): EPS=10.04 | Chg7d=+0.000 | Chg30d=+0.223 | Revisions Net=+14 | Growth EPS=+14.9% | Growth Revenue=+5.7%
EPS next Year (2027-12-31): EPS=11.00 | Chg7d=+0.000 | Chg30d=+0.288 | Revisions Net=+12 | Growth EPS=+9.5% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: +1.00 (8 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 9.8% - Earnings Yield 6.2%)
[Growth] Growth Spread = +2.5% (Analyst 6.2% - Implied 3.7%)